- United States
- /
- Chemicals
- /
- NYSE:ECL
Ecolab (ECL) Valuation Check As Shares Move Without A Clear News Catalyst
Ecolab stock moves without a clear news catalyst
Ecolab (ECL) shares have been active recently, even without a specific headline event. This has prompted investors to look more closely at its current valuation, recent returns and the scale of its global operations.
See our latest analysis for Ecolab.
At a recent share price of $270.37, Ecolab has seen modest pressure in the short term, with 30-day and 90-day share price returns of 1.00% and 2.65% declines. Longer term total shareholder returns of 15.77% over one year and 69.44% over three years point to momentum built over time.
If Ecolab’s move has you thinking about where else capital might work hard for you, it could be worth scanning 19 top founder-led companies
So with Ecolab posting steady revenue and net income growth, a market value of about US$77.1b and a recent price around US$270, is there still potential upside available, or is the market already fully pricing in future growth?
Most Popular Narrative: 15% Undervalued
The most followed valuation narrative puts Ecolab’s fair value at $319.29 per share, compared with the recent price of $270.37. This frames the current debate around upside potential at today’s level.
Ecolab is focusing on expanding its One Ecolab growth initiative, aiming to capitalize on market share gains and increased value pricing. This initiative is expected to drive revenue growth and improve net margins by delivering exceptional value to customers.
Want to see what sits behind that confidence in higher margins and revenue? The narrative leans on sustained growth, richer pricing power and a premium earnings multiple that many investors usually associate with faster growing sectors.
Result: Fair Value of $319.29 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there are still pressure points, with softer heavy industrial demand, rising tariffs, and increasing local supplier costs that could squeeze margins and challenge the upbeat narrative.
Find out about the key risks to this Ecolab narrative.
Another Take: What Earnings Multiples Are Signalling
The 15% undervalued narrative sits awkwardly next to Ecolab’s current P/E of 36.8x, which is much richer than the US Chemicals industry at 29.5x, the peer average at 30.1x, and even its own fair ratio of 25.7x. That gap suggests valuation risk that investors need to weigh carefully. Is the premium simply the price of quality, or a stretch that leaves less room for error?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mix of confidence and caution in the story so far, it makes sense to review the underlying data yourself. You can then decide quickly where you stand, starting with 1 key reward and 1 important warning sign
Looking for more investment ideas?
If Ecolab has sharpened your focus, do not stop here, the right mix of other opportunities could matter just as much for your long term returns.
- Spot potential value opportunities early by scanning 60 high quality undervalued stocks that may offer quality businesses at prices below their implied worth.
- Prioritise resilience in tougher markets by checking 72 resilient stocks with low risk scores that score well on stability and risk controls.
- Hunt for tomorrow’s quiet overachievers by reviewing the screener containing 23 high quality undiscovered gems that most investors may not be watching yet.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Ecolab might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:ECL
Ecolab
Provides water, hygiene, and infection prevention solutions and services in the United States and internationally.
Average dividend payer with mediocre balance sheet.
Similar Companies
Market Insights
Weekly Picks

OPTH: A licensed manufacturer already selling MDMA while peers still wait on trials

Why Amdocs is a high conviction Buy for me?
Why SBM Offshore’s €30 Share Price May Be Too Harsh On Its Backlog

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend
Recently Updated Narratives
Lagenda Properties 录得创纪录销售额与收入,推动盈利能见度提升

STLLR Gold, Eric Sprott + Agnico Backed: Massive Canadian Gold Developer at Junior Prices
High-Growth Emerging Commercial Stage Biotech
Popular Narratives


